UK psychiatrists question SSRI warnings for under-18s

Meek, Colin
February 2004
CMAJ: Canadian Medical Association Journal;2/17/2004, Vol. 170 Issue 4, p455
Academic Journal
Reports on the concern expressed by British psychiatrists about regulatory action to curb the use of most selective serotonin reuptake inhibitors (SSRI) to treat depression in children and adolescent. Warning issued by the British Committee on Safety of Medicines regarding the use of SSRI; Guidelines released by the National Institute of Clinical Excellence about antidepressants; Comments from John Geddes, a professor of epidemiological psychiatry at Oxford University.


Related Articles

  • Current Issues & Opinions.  // Reactions Weekly;1/10/2004, Issue 983, p3 

    Discusses research being done on the recommended treatments for major depressive disorder in children and adolescents. Reference to a study by Paul Ramchandani published in the January 3, 2004 issue of "British Medical Journal"; Selective serotonin reuptake inhibitor that has a favorable...

  • Controversy exists in the use of selective serotonin reuptake inhibitors in children and adolescents. Adis International Limited // Drugs & Therapy Perspectives;May2005, Vol. 21 Issue 5, p20 

    Focuses on the warnings issued in the administration of selective serotonin reuptake inhibitors (SSRI) among children and adolescents due to the increased risk of suicidal behavior among its patients. Efficacy of fluoxetine in treating depression and psychiatric illness in children; Adverse...

  • Use of SSRI antidepressants in children and adolescents.  // WHO Drug Information;2004, Vol. 18 Issue 1, p20 

    Reports on the Australian Adverse Drug Reactions Advisory Committee's recommendations on the use of selective serotonin reuptake inhibitor antidepressants in children and adolescents. Concerns on the possibility of increased suicidal ideation and self-harm behavior provoked by the drugs;...

  • Which drugs are most effective for moderate to severe depression in adolescents? Guirguis-Blake, Janelle; Wright, Andrew; Rich, Joanne // Journal of Family Practice;May2008, Vol. 57 Issue 5, p330 

    The article reports on the study conducted on which medication is safe in treating moderate to severe depression in adolescents in the U.S. Research shows that fluoxetine is the only selective serotonin-reuptake inhibitor (SSRI) approved by the Food and Drug Administration to treat depression in...

  • Perspectives on the Efficacy of Antidepressants for Child and Adolescent Depression. Raz, Amir // PLoS Medicine;Jan2006, Vol. 3 Issue 1, pe9 

    The article presents information on a study on the efficacy of antidepressants for child and adolescent depression (CAD). According to the article, selective serotonin reuptake inhibitors have become the top-selling drug category since being introduced in the U.S. in 1989. The study concluded...

  • Depression in Children and Adolescents.  // American Family Physician;11/15/2000, Vol. 62 Issue 10, p2297 

    Depression among children and adolescents is common but frequently unrecognized. It affects 2 percent of prepubertal children and 5 to 8 percent of adolescents. The clinical spectrum of the disease can range from simple sadness to a major depressive or bipolar disorder. Risk factors include a...

  • Fluoxetine approved for children and adolescents.  // WHO Drug Information;2006, Vol. 20 Issue 2, p89 

    The article reports on the recommendation of the European Medicines Agency (EMEA) to extend the indication of fluoxetine for the treatment of mental depression in children aging 8 years older who do not respond to psychological therapy. EMEA ended that fluoxetine is beneficial and that the...

  • A Review of Escitalopram and Citalopram in Child and Adolescent Depression. Carandang, Carlo; Jabbal, Rekha; MacBride, Angela; Elbe, Dean // Journal of the Canadian Academy of Child & Adolescent Psychiatry;2011, Vol. 20 Issue 4, p315 

    Objective: To review the basic pharmacology and published literature regarding escitalopram and citalopram in child and adolescent depression. Methods: A literature review was conducted using the search terms: 'escitalopram', 'citalopram', 'depression', 'randomized controlled trial', 'open label...

  • DEPRESSION DRUGS FOR KIDS: HOW SAFE?  // Time;2/2/2004, Vol. 163 Issue 5, p78 

    Reports on the controversy among medical professionals about whether it is safe to give drugs known as selective serotonin-reuptake inhibitors (SSRIs) to depressed children and teenagers. Warning by British health care officials that doctors should avoid giving any SSRI but Prozac to children,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics